Literature DB >> 19162054

Long-term behavioral consequences of prenatal MDMA exposure.

Valerie B Thompson1, Justin Heiman, James B Chambers, Stephen C Benoit, William R Buesing, Mantana K Norman, Andrew B Norman, Jack W Lipton.   

Abstract

The current study sought to determine whether prenatal 3,4-methylenedioxy-N-methamphetamine (MDMA) exposure from E14-20 in the rat resulted in behavioral sequelae in adult offspring. Prenatal MDMA exposure results in increased dopaminergic fiber density in the prefrontal cortex, striatum and nucleus accumbens of young rats. Since these areas are critical in response to novelty, reward, attention and locomotor activity, we hypothesized that prenatal MDMA exposure would produce significant changes in the performance of tasks that examine such behaviors in adult rats. Adult rats prenatally exposed to MDMA exhibited greater activity and spent more time in the center during a novel open field test as compared to controls. This increased activity was not reflected in normal home cage activity. Prenatal exposure to MDMA did not affect feeding or food reward. It did not alter cocaine self-administration behaviors, nor did it have an effect on the locomotor response to amphetamine challenge. Finally, while prenatal MDMA did not affect performance in the radial arm maze or the Morris water maze (MWM), these animals demonstrated altered performance in a cued MWM paradigm. Prenatal MDMA exposure resulted in perseverative attendance to a hanging cue when the platform in the MWM was removed as compared to controls. Together, these data demonstrate that prenatal exposure to MDMA results in a behavioral phenotype in adult rats characterized by reduced anxiety, a heightened response to novelty, and "hyperattentiveness" to environmental cues during spatial learning.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19162054      PMCID: PMC2649789          DOI: 10.1016/j.physbeh.2008.12.013

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  67 in total

1.  Perseverative interference with object-in-place scene learning in rhesus monkeys with bilateral ablation of ventrolateral prefrontal cortex.

Authors:  Mark G Baxter; Philip G F Browning; Anna S Mitchell
Journal:  Learn Mem       Date:  2008-02-22       Impact factor: 2.460

Review 2.  The Naples High- and Low-Excitability rats: selective breeding, behavioral profile, morphometry, and molecular biology of the mesocortical dopamine system.

Authors:  Davide Viggiano; Daniela Vallone; Hans Welzl; Adolfo G Sadile
Journal:  Behav Genet       Date:  2002-09       Impact factor: 2.805

3.  Functional consequences of perinatal exposure to 3,4-methylenedioxymethamphetamine in rat brain.

Authors:  Paul A T Kelly; Isobel M Ritchie; Linda Quate; Douglas E McBean; Henry J Olverman
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

4.  Short- and long-term effects of (+)-methamphetamine and (+/-)-3,4-methylenedioxymethamphetamine on monoamine and corticosterone levels in the neonatal rat following multiple days of treatment.

Authors:  Tori L Schaefer; Matthew R Skelton; Nicole R Herring; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

5.  Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects or injection stress.

Authors:  Michael T Williams; LaRonda L Morford; Sandra L Wood; Stephanie L Rock; Anne E McCrea; Masao Fukumura; Tanya L Wallace; Harry W Broening; Mary S Moran; Charles V Vorhees
Journal:  Brain Res       Date:  2003-04-04       Impact factor: 3.252

6.  Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.

Authors:  James B Koprich; Er-Yun Chen; Nicholas M Kanaan; Nicholas G Campbell; Jeffrey H Kordower; Jack W Lipton
Journal:  Neurotoxicol Teratol       Date:  2003 Sep-Oct       Impact factor: 3.763

7.  Switching to cue-directed behavior: specific for ventral striatal dopamine but not ventral pallidum/substantia innominata gaba as revealed by a swimming-test procedure in rats.

Authors:  R van den Bos; A R Cools
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

8.  Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat.

Authors:  Jon F Davis; Andrea L Tracy; Jennifer D Schurdak; Matthias H Tschöp; Jack W Lipton; Deborah J Clegg; Stephen C Benoit
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

9.  Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion.

Authors:  Clint G Gurtman; Kirsten C Morley; Kong M Li; Glenn E Hunt; Iain S McGregor
Journal:  Eur J Pharmacol       Date:  2002-06-20       Impact factor: 4.432

10.  Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis.

Authors:  Gersh Z Taicher; Frank C Tinsley; Arcady Reiderman; Mark L Heiman
Journal:  Anal Bioanal Chem       Date:  2003-09-16       Impact factor: 4.142

View more
  12 in total

1.  Glucocorticoid receptors in the nucleus of the solitary tract (NTS) decrease endocrine and behavioral stress responses.

Authors:  Sriparna Ghosal; Jana Bundzikova-Osacka; C Mark Dolgas; Brent Myers; James P Herman
Journal:  Psychoneuroendocrinology       Date:  2014-04-06       Impact factor: 4.905

Review 2.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

Review 3.  Illicit substance use in pregnancy - a review.

Authors:  Katherine Scott; Karin Lust
Journal:  Obstet Med       Date:  2010-09-17

4.  MDMA enhances hippocampal-dependent learning and memory under restrictive conditions, and modifies hippocampal spine density.

Authors:  Sònia Abad; Alberto Fole; Nuria del Olmo; David Pubill; Mercè Pallàs; Fèlix Junyent; Jorge Camarasa; Antonio Camins; Elena Escubedo
Journal:  Psychopharmacology (Berl)       Date:  2013-10-26       Impact factor: 4.530

5.  Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat.

Authors:  V B Thompson; J B Koprich; E Y Chen; J H Kordower; B T Terpstra; J W Lipton
Journal:  Neurotoxicol Teratol       Date:  2011-09-28       Impact factor: 3.763

Review 6.  Methamphetamine: burden, mechanism and impact on pregnancy, the fetus, and newborn.

Authors:  Deepika Sankaran; Satyan Lakshminrusimha; Veena Manja
Journal:  J Perinatol       Date:  2021-11-16       Impact factor: 2.521

7.  Illicit drug use in late pregnancy associated with stillbirth and eclampsia.

Authors:  Katherine Scott; Narelle Fagermo; Leonie Callaway; Karin Lust
Journal:  Obstet Med       Date:  2010-09-17

8.  One-year outcomes of prenatal exposure to MDMA and other recreational drugs.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Pediatrics       Date:  2012-08-20       Impact factor: 7.124

9.  Motor delays in MDMA (ecstasy) exposed infants persist to 2 years.

Authors:  Lynn T Singer; Derek G Moore; Meeyoung O Min; Julia Goodwin; John J D Turner; Sarah Fulton; Andrew C Parrott
Journal:  Neurotoxicol Teratol       Date:  2016-01-21       Impact factor: 3.763

10.  Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists.

Authors:  Sarah Bradbury; David Gittings; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2012-05-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.